Clinical trial
A Clinical Trial to Explore the Safety and Efficacy of Injections of Macugen…
NCT00354445 · Eyetech Pharmaceuticals, Industry · Unknown status
Key facts
| NCT number | NCT00354445 |
|---|---|
| Title | A Clinical Trial to Explore the Safety and Efficacy of Injections of Macugen When Given Every 6 Weeks in Subjects With AMD |
| Official title | A Phase IV, Open Label, Multi-Center, Study of Maintenance Intravitreous Injections of Macugen (Pegaptanib Sodium) Given Every 6 Weeks for 48 Weeks in Subjects With Subfoveal Neovascular Age-Related Macular Degeneration (AMD) Initially Treated With a Modality Resulting in Maculopathy Improvement |
| Lead sponsor | Eyetech Pharmaceuticals, Industry |
| Collaborators | Pfizer Industry |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Age-Related Macular Degeneration (AMD) |
| Intervention type | Drug |
| Interventions | pegaptanib sodium (Macugen) |
| Enrollment | 1,000 |
| Start date | Jun 1, 2006 |
| First posted | Jul 20, 2006 |
| Last update posted | Jan 15, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: